Dolby Laboratories, Inc. Restricted Cash and Cash Equivalents
Dolby Laboratories, Inc. (DLB) had Restricted Cash and Cash Equivalents of $69.49 million as of 2026-06-26, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Assets
us-gaap:RestrictedCashAndCashEquivalents · last filed 2026-07-30
- 2026-06-26: Restricted Cash and Cash Equivalents $69.49M.
- 2026-03-27: Restricted Cash and Cash Equivalents $79.52M.
- 2025-12-26: Restricted Cash and Cash Equivalents $83.72M.
- 2025-09-26: Restricted Cash and Cash Equivalents $91.47M.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2026-06-26 | $69.49M 10-Q · filed 2026-07-30 |
| 2026-03-27 | $79.52M 10-Q · filed 2026-04-30 |
| 2025-12-26 | $83.72M 10-Q · filed 2026-01-29 |
| 2025-09-26 | $91.47M 10-Q · filed 2026-07-30 |
| 2025-06-27 | $58.00M 10-Q · filed 2025-07-31 |
| 2025-03-28 | $123.79M 10-Q · filed 2025-05-01 |
| 2024-12-27 | $90.84M 10-Q · filed 2025-01-30 |
| 2024-09-27 | $95.70M 10-K · filed 2025-11-18 |
| 2024-06-28 | $36.99M 10-Q · filed 2024-08-07 |
| 2024-03-29 | $114.82M 10-Q · filed 2024-05-02 |
| 2023-12-29 | $51.84M 10-Q · filed 2024-02-02 |
| 2023-09-29 | $72.60M 10-K · filed 2024-11-19 |
| 2023-06-30 | $34.08M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $4.98M 10-Q · filed 2023-05-05 |
| 2022-12-30 | $5.32M 10-Q · filed 2023-02-02 |
| 2022-09-30 | $8.24M 10-K · filed 2023-11-17 |
| 2022-07-01 | $8.35M 10-Q · filed 2022-08-09 |
| 2022-04-01 | $8.45M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $7.75M 10-Q · filed 2022-02-04 |
| 2021-09-24 | $7.65M 10-K · filed 2022-11-18 |
| 2021-06-25 | $7.60M 10-Q · filed 2021-07-29 |
| 2021-03-26 | $8.93M 10-Q · filed 2021-05-04 |
| 2020-12-25 | $9.40M 10-Q · filed 2021-01-29 |
| 2020-09-25 | $8.10M 10-K · filed 2021-11-17 |
| 2020-06-26 | $8.29M 10-Q · filed 2020-08-03 |
| 2020-03-27 | $9.51M 10-Q · filed 2020-05-04 |
| 2019-12-27 | $11.73M 10-Q · filed 2020-01-29 |
| 2019-09-27 | $8.38M 10-K · filed 2020-11-16 |
| 2019-06-28 | $7.49M 10-Q · filed 2019-08-02 |
| 2019-03-29 | $8.27M 10-Q · filed 2019-05-08 |
| 2018-12-28 | $9.00M 10-Q · filed 2019-02-01 |
| 2018-09-28 | $7.19M 10-K · filed 2019-11-25 |
| 2018-06-29 | $7.84M 10-Q · filed 2018-08-01 |
| 2018-03-30 | $8.08M 10-Q · filed 2018-05-02 |
| 2017-12-29 | $7.63M 10-Q · filed 2018-01-31 |
| 2017-09-29 | $7.35M 10-K · filed 2018-11-15 |
| 2017-06-30 | $6.19M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $5.75M 10-Q · filed 2017-05-03 |
| 2016-12-30 | $5.08M 10-Q · filed 2017-02-02 |
| 2016-09-30 | $3.65M 10-K · filed 2017-11-16 |
| 2016-07-01 | $5.67M 10-Q · filed 2016-08-02 |
| 2016-04-01 | $5.28M 10-Q · filed 2016-05-04 |
| 2016-01-01 | $4.33M 10-Q · filed 2016-02-05 |
| 2015-09-25 | $2.94M 10-K · filed 2016-11-18 |
| 2015-06-26 | $1.92M 10-Q · filed 2015-07-31 |
| 2015-03-27 | $2.16M 10-Q · filed 2015-05-06 |
| 2014-12-26 | $2.04M 10-Q · filed 2015-01-30 |
| 2014-09-26 | $2.14M 10-K · filed 2015-11-24 |
| 2014-06-27 | $3.33M 10-Q · filed 2014-07-30 |
| 2014-03-28 | $3.34M 10-Q · filed 2014-04-30 |
| 2013-12-27 | $3.35M 10-Q · filed 2014-01-29 |
| 2013-09-27 | $3.17M 10-K · filed 2014-11-18 |